Chan Frank 4

What Happened Frank Chan, Chief Operating Officer of Haemonetics Corporation (HAE), was granted 27,535 restricted stock units (RSUs) on May 15, 2026. To cover tax obligations on the vesting event, 546 shares were withheld/disposed at $56.29 per share, totaling $30,734. The RSUs are awards (code A) and the withholding is reported as tax withholding (code F).

Key Details

• Transaction date: 2026-05-15; filing date: 2026-05-19 (timely filing).
• Withheld shares: 546 shares withheld at $56.29/share for taxes — proceeds $30,734 (disposition code F).
• Award: 27,535 RSUs granted (acquisition code A); monetary value not stated in filing.
• Post-transaction holdings: filing indicates the RSUs plus previously reported unvested RSUs and ESPP purchases (139 shares on 2025-10-31 and 119 shares on 2026-04-30); total share count after the grant is not explicitly stated in the summary provided.
• Footnotes: F1 = withholding for tax obligations; F2 = includes previously reported unvested RSUs and two recent ESPP purchases (139 and 119 shares); F3 = RSUs vest 40%/40%/20% over three years; F4 = each RSU converts to one common share when vested.

Context

• RSU grants are compensation awards (not open-market purchases) and typically reflect company pay programs rather than an immediate bullish bet by the insider.
• The tax-withholding move is routine (covering tax liability upon grant/vesting) and should not be read as a standard "sale" for sentiment.
• Purchases (open-market buys) tend to be more directly informative of insider conviction; awards primarily reflect compensation policy and retention incentives.